ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Free cash flow 2016–2024
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$74.1MFY2024 · since FY2016: -$59.7M → -$74.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$74.1M | +49.1% |
| FY2023 | -$145.6M | +15.0% |
| FY2022 | -$171.3M | -8047.3% |
| FY2021 | $2.2M | +103.9% |
| FY2020 | -$55.9M | +51.0% |
| FY2019 | -$114.1M | -5.4% |
| FY2018 | -$108.3M | -37.2% |
| FY2017 | -$79.0M | -32.3% |
| FY2016 | -$59.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice